Thrombosis Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Curr Opin Pulm Med. 2013 Sep;19(5):407-12. doi: 10.1097/MCP.0b013e328363ed7c.
Venous thromboembolism (VTE) is a chronic disease, associated with a significant rate of recurrence, lower in patients with events provoked by transient risk factors and higher in unprovoked cases. Short-term treatment is indicated for provoked VTE, long-term treatment should be considered for unprovoked. The aim of this review is to evaluate the risk factors for recurrence and the decisional algorithms available to guide patients' management.
To identify patients who carry a high recurrent risk and require long-term treatment, three algorithms have been proposed: the HERDOO2, the Vienna prediction model, and the DASH score. All identify male sex and elevated D-dimer levels as important risk factors for recurrence. However, important differences among the models should be outlined: in the HERDOO2 model, D-dimer levels are measured during anticoagulation and not after its withdrawal; furthermore, it indicates age greater than 65 as a risk factor for recurrence, whereas the DASH score attributes a higher risk to age less than 50. The Vienna model is complex for routine use.
Further studies are needed to clarify these discrepancies. A management study based on D-dimer levels after anticoagulation withdrawal is ongoing and could indicate a simple way to safely manage these patients.
静脉血栓栓塞症(VTE)是一种慢性疾病,其复发率较高,由短暂风险因素引起的事件患者复发率较低,无诱因的患者复发率较高。有诱因的 VTE 需要短期治疗,无诱因的 VTE 需要长期治疗。本文旨在评估复发的风险因素,并提供可用的决策算法来指导患者的管理。
为了识别具有高复发风险且需要长期治疗的患者,已经提出了三种算法:HERDOO2、维也纳预测模型和 DASH 评分。所有这些算法都将男性和升高的 D-二聚体水平作为复发的重要危险因素。然而,这些模型之间存在重要差异:在 HERDOO2 模型中,D-二聚体水平在抗凝治疗期间而不是在抗凝治疗停止后进行测量;此外,该模型将年龄大于 65 岁作为复发的危险因素,而 DASH 评分则将年龄小于 50 岁的患者视为高风险人群。维也纳模型对于常规使用来说比较复杂。
需要进一步的研究来阐明这些差异。一项基于抗凝治疗停止后 D-二聚体水平的管理研究正在进行中,这可能为安全管理这些患者提供一种简单的方法。